Estimation and enhancement of in vitro corneal transport of S-1033, a novel antiglaucoma medication
- 1 April 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 132 (1-2) , 165-173
- https://doi.org/10.1016/0378-5173(95)04372-1
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Role of Enzymatic Lability in the Corneal and Conjunctival Penetration of Timolol Ester Prodrugs in the Pigmented RabbitPharmaceutical Research, 1991
- Influence of some preservatives on the corneal permeability of pilocarpine and dexamethasone, in vitroInternational Journal of Pharmaceutics, 1987
- Factors influencing the corneal permeability of prostaglandin F2α and its isopropyl ester in vitroInternational Journal of Pharmaceutics, 1987
- Detergent penetration into young and adult rabbit eyes: comparative pharmacokineticsJournal of Toxicology- Cutaneous and Ocular Toxicology, 1987
- Systemic Side Effects from Ophthalmic Timolol and Their PreventionJournal of Ocular Pharmacology and Therapeutics, 1987
- Permeability of prostaglandin F2α and prostaglandin F2α esters across cornea in vitroInternational Journal of Pharmaceutics, 1986
- Relationship of Chemical Structure to Corneal Penetration and Influence of Low-Viscosity Solution on Ocular BioavailabilityJournal of Pharmaceutical Sciences, 1984
- Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2αCurrent Eye Research, 1981
- Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrierExperimental Eye Research, 1977
- Practical Aspects of Ophthalmic Drug DevlopmentDrug Development and Industrial Pharmacy, 1977